Stifel Financial
AXDX

Stifel Financial’s Accelerate Diagnostics AXDX Stock Holding History

Stifel Financial’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,000
Closed -$8.1K – 3287
2023
Q2 		$8.1K Hold
1,000
– – ﹤0.01% 3306
2023
Q1 		$7K Hold
1,000
– – ﹤0.01% 3317
2022
Q4 		$7.06K Hold
1,000
– – ﹤0.01% 3276
2022
Q3 		$15K Hold
1,000
– – ﹤0.01% 3247
2022
Q2 		$10K Hold
1,000
– – ﹤0.01% 3299
2022
Q1 		$14K Hold
1,000
– – ﹤0.01% 3353
2021
Q4 		$52K Hold
1,000
– – ﹤0.01% 3310
2021
Q3 		$58K Hold
1,000
– – ﹤0.01% 3271
2021
Q2 		$81K Hold
1,000
– – ﹤0.01% 3251
2021
Q1 		$83K Hold
1,000
– – ﹤0.01% 3136
2020
Q4 		$76K Hold
1,000
– – ﹤0.01% 2958
2020
Q3 		$107K Hold
1,000
– – ﹤0.01% 2745
2020
Q2 		$152K Sell
1,000
-129
-11% -$12.7K ﹤0.01% 2648
2020
Q1 		$95K Sell
1,129
-42,910
-97% -$6.04M ﹤0.01% 2598
2019
Q4 		$7.42M Sell
44,039
-6,358
-13% -$1.05M 0.02% 717
2019
Q3 		$9.38M Sell
50,397
-13,408
-21% -$2.59M 0.02% 584
2019
Q2 		$14.6M Sell
63,805
-1,389
-2% -$272K 0.04% 435
2019
Q1 		$13.8M Buy
65,194
+9,518
+17% +$1.78M 0.04% 428
2018
Q4 		$6.37M Buy
55,676
+11,003
+25% +$1.63M 0.02% 661
2018
Q3 		$10.3M Buy
+44,673
New +$9.88M 0.03% 538
2017
Q4 		– Sell
-2,677
Closed -$594K – 2656
2017
Q3 		$594K Buy
2,677
+122
+5% +$30K ﹤0.01% 1781
2017
Q2 		$693K Buy
2,555
+1,410
+123% +$382K ﹤0.01% 1684
2017
Q1 		$274K Buy
+1,145
New +$262K ﹤0.01% 2150
2016
Q3 		– Sell
-3,384
Closed -$487K – 2393
2016
Q2 		$487K Buy
+3,384
New +$454K ﹤0.01% 1769
2015
Q4 		– Sell
-3,209
Closed -$518K – 2333
2015
Q3 		$518K Buy
+3,209
New +$694K ﹤0.01% 1530

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $160M AUM 15.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stifel Financial's AXDX Position: Q3 2023 in Review

Stifel Financial sold out of Accelerate Diagnostics (AXDX) in Q3 2023, closing a stake of 1,000 shares — an estimated $8.1K sold.

Stifel Financial first reported a position in AXDX in Q3 2015 and held it in 25 quarters. The position peaked at $14.6M in Q2 2019. 38 funds tracked by Wall St. Rank hold AXDX as of Q3 2023.

  • Stifel Financial reported no remaining Accelerate Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Stifel Financial sold 1,000 Accelerate Diagnostics shares in Q3 2023, an estimated $8.1K.
  • Stifel Financial first reported a position in Accelerate Diagnostics in Q3 2015 and held it in 25 quarters.
  • Stifel Financial's Accelerate Diagnostics position peaked at $14.6M in Q2 2019.
  • 38 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2023.

Based on Stifel Financial's 13F filing for Q3 2023, filed 13 Nov 2023.